Statin intolerance: myths and facts-Reference-Cited by-同舟云学术

Statin intolerance: myths and facts

Published:2020-07-23 Issue:35 Volume:41 Page:3343-3345
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Laufs Ulrich¹^ORCID,Isermann Berend²^ORCID

Affiliation:

1. Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Liebigstraße 20, D-04103 Leipzig, Germany

2. Institut für Laboratoriumsmedizin, Klinische Chemie und Molekulare Diagnostik, Universitätsklinikum Leipzig, Paul-List Straße 13–15, D-04103 Leipzig, Germany

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/41/35/3343/33855979/ehaa582.pdf

Reference16 articles.

1. Statin intolerance: reconciling clinical trials and clinical experience;Newman;JAMA,2015

2. European Atherosclerosis Society Consensus Panel. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management;Stroes;Eur Heart J,2015

3. Efficacy and safety of bempedoic acid in patients with hypercholesterolemia and statin intolerance;Laufs;J Am Heart Assoc,2019

4. The National Lipid Association’s Muscle Safety Expert Panel. An assessment by the Statin Muscle Safety Task Force: 2014 update;Rosenson;J Clin Lipidol,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life in patients with statin intolerance: a multicentre prospective registry study;The Lancet Regional Health - Europe;2024-08

2. Percorso diagnostico e terapeutico della dislipidemia nel paziente ad alto rischio cardiovascolare;Gazzetta Medica Italiana Archivio per le Scienze Mediche;2024-08

3. Management of a patient at very high cardiovascular risk with myositis during high-intensity statin therapy;Meditsinskiy sovet = Medical Council;2024-05-19

4. LDL cholesterol target attainment in cardiovascular high- and very-high-risk patients with statin intolerance: a simulation study;Scientific Reports;2024-01-04

5. Advances in the treatment of atherosclerosis with ligand‐modified nanocarriers;Exploration;2023-12-07